熱門資訊> 正文
模块化医疗报告美国专利发布，涵盖核心泵送技术关键方面
2024-09-18 20:34
- Modular Medical (NASDAQ:MODD) Wednesday announced the issuance of U.S. Divisional Patent Application No. 17/968,599.
- "The issuance of this patent and the associated claims represent a major step in our efforts to protect the intellectual property in the MODD1 pump platform," stated Jeb Besser, CEO of Modular Medical.
- "Some of the key features of our novel, low-cost and accurate insulin delivery technology are now protected by this important issued U.S. patent, which we believe represents a significant new barrier to entry."
- MODD +2.20% premarket to $2.32.
- Source: Press Release
More on Modular Medical, Inc.
- Modular Medical initiates transfer of manufacturing operations to Phillips Medisize
- Seeking Alpha’s Quant Rating on Modular Medical, Inc.
- Historical earnings data for Modular Medical, Inc.
- Financial information for Modular Medical, Inc.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
